Chile vs Tajikistan: Cause of death, by non-communicable diseases, ages 60+
Chile
76.7%
in 2021
Tajikistan
76.1%
in 2021
Chile rank
67th
Tajikistan rank
70th
Cause of death, by non-communicable diseases, ages 60+ over time
- Chile
- Tajikistan
How they compare
Chile currently reports 76.7% against 76.1% in Tajikistan, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Tajikistan ahead.
Chile ranks 67th and Tajikistan ranks 70th of 185 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Chile | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.4% | 93.7% | 7.4% | Tajikistan |
| 2010s | 88.6% | 94.5% | 5.9% | Tajikistan |
| 2020s | 76.3% | 73.9% | 2.4% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Chile or Tajikistan?
- Chile, at 76.7% against 76.1% in Tajikistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Chile and Tajikistan?
- 0.6%, with Chile ahead.
- How many years of comparable data are there for Chile and Tajikistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Tajikistan rank globally for cause of death, by non-communicable diseases, ages 60+?
- Chile ranks 67th and Tajikistan ranks 70th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.